SCHEMBL3658134

SCHEMBL3658134

N=C(NO)c1cn(C2OC(CO)C(O)C2O)c2ncnc(NO)c12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 2/20 0.72
▸ TP53 P04637 1/20 0.72
▸ STAT6 P42226 1/20 0.72
▸ ADK P55263 8/20 0.58
▸ PAX8 Q06710 2/20 0.55
▸ NPC1 O15118 1/20 0.55
▸ GALR3 O60755 1/20 0.55
▸ S1PR4 O95977 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ S1PR1 P21453 1/20 0.55
▸ HTT P42858 1/20 0.55
▸ RAB9A P51151 1/20 0.55
▸ SLC29A1 Q99808 1/20 0.53
▸ DOT1L Q8TEK3 2/20 0.50
▸ SIGMAR1 Q99720 3/20 0.49
▸ HTR2B P41595 2/20 0.49
▸ ADRA2C P18825 1/20 0.49
▸ OPRK1 P41145 1/20 0.49
▸ HTR6 P50406 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2788442 0.88 HIF1A (0.57) HIF1ATP53STAT6ADKPAX8
SCHEMBL2784932 0.87 HIF1A (0.69) HIF1ATP53STAT6ADKPAX8
SCHEMBL26031534 0.86 HIF1A (0.80) HIF1ATP53STAT6ADKPAX8
SCHEMBL2786324 0.86 HIF1A (0.55) HIF1ATP53STAT6ADKPAX8
SCHEMBL13021259 0.86 HIF1A (0.55) HIF1ATP53STAT6ADKPAX8
SCHEMBL3658127 0.84 HIF1A (1.00) HIF1ATP53STAT6ADKPAX8
SCHEMBL3658125 0.84 HIF1A (1.00) HIF1ATP53STAT6ADKPAX8
Hydrochloric Acid SCHEMBL2386489 0.83 HIF1A (0.98) HIF1ATP53STAT6ADKPAX8
SCHEMBL25350905 0.83 TP53 (0.68) HIF1ATP53STAT6ADKSLC29A1
SCHEMBL30536291 0.83 TP53 (0.68) HIF1ATP53STAT6ADKSLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2214670-A2 COMPOUNDS FOR TREATING ABNORMAL CELLULAR PROLIFERATION Taiga Biotechnologies, Inc. (US) 2010-08-11 — — EP disclosed
WO-2009059304-A2 COMPOUNDS FOR TREATING ABNORMAL CELLULAR PROLIFERATION TAIGA BIOTECHNOLOGIES, INC. (US) 2009-05-07 — — WO disclosed
Send feedback